TR201009398A2 - Fiziksel özellikleri geliştirilmiş tablet formülasyonları - Google Patents
Fiziksel özellikleri geliştirilmiş tablet formülasyonlarıInfo
- Publication number
- TR201009398A2 TR201009398A2 TR2010/09398A TR201009398A TR201009398A2 TR 201009398 A2 TR201009398 A2 TR 201009398A2 TR 2010/09398 A TR2010/09398 A TR 2010/09398A TR 201009398 A TR201009398 A TR 201009398A TR 201009398 A2 TR201009398 A2 TR 201009398A2
- Authority
- TR
- Turkey
- Prior art keywords
- physical properties
- improved physical
- tablet formulations
- locotriene
- antihistaminic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/09398A TR201009398A2 (tr) | 2010-11-11 | 2010-11-11 | Fiziksel özellikleri geliştirilmiş tablet formülasyonları |
| PCT/TR2011/000243 WO2012064301A2 (fr) | 2010-11-11 | 2011-11-03 | Formulations de comprimés aux propriétés physiques améliorées |
| PCT/TR2011/000247 WO2012064305A2 (fr) | 2010-11-11 | 2011-11-03 | Formulations ayant des caractéristiques physiques améliorées |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/09398A TR201009398A2 (tr) | 2010-11-11 | 2010-11-11 | Fiziksel özellikleri geliştirilmiş tablet formülasyonları |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201009398A2 true TR201009398A2 (tr) | 2012-05-21 |
Family
ID=45446164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2010/09398A TR201009398A2 (tr) | 2010-11-11 | 2010-11-11 | Fiziksel özellikleri geliştirilmiş tablet formülasyonları |
Country Status (2)
| Country | Link |
|---|---|
| TR (1) | TR201009398A2 (fr) |
| WO (2) | WO2012064305A2 (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20130050952A (ko) | 2010-06-16 | 2013-05-16 | 브루스 챈들러 메이 | 인플루엔자, 감기 및 염증의 치료에서 레보세티리진 및 몬테루카스트의 용도 |
| RU2677649C2 (ru) * | 2013-02-21 | 2019-01-18 | Глэнмарк Фармасьютикалс Лимитед | Фармацевтические композиции монтелукаста и левоцетиризина |
| CA2901413A1 (fr) | 2013-03-13 | 2014-10-09 | Bruce Chandler May | Utilisation de levocetirizine et de montelukast dans le traitement de la vascularite |
| ES2654093T3 (es) | 2013-03-13 | 2018-02-12 | Inflammatory Response Research, Inc. | Uso de levocetirizina y montelukast en el tratamiento de trastornos autoinmunes |
| RU2672871C2 (ru) | 2013-03-13 | 2018-11-20 | Инфламматори Респонс Ресёрч, Инк. | Применение левоцетиризина и монтелукаста при лечении травматических повреждений |
| WO2015163978A1 (fr) | 2014-04-25 | 2015-10-29 | R.P. Scherer Technologies, Llc | Solution stable de montélukast |
| JP2017526728A (ja) | 2014-09-15 | 2017-09-14 | インフラマトリー・レスポンス・リサーチ・インコーポレイテッド | 炎症介在性状態の治療におけるレボセチリジン及びモンテルカスト |
| EP3222279B1 (fr) | 2016-03-21 | 2021-11-17 | Invest Bielany Spolka z ograniczona odpowiedzialnoscia | Préparation pharmaceutique orale de montélukast et de lévocétirizine et procédé pour sa production |
| WO2017210417A1 (fr) * | 2016-06-03 | 2017-12-07 | Inflammatory Response Research, Inc. | Lévocétirizine et montélukast dans le traitement d'états pathologiques médiés par une exposition à des rayonnements |
| KR102110304B1 (ko) * | 2017-06-30 | 2020-05-14 | 한미약품 주식회사 | 레보세티리진 및 몬테루카스트를 포함하는 안정성 및 복약순응도가 향상된 복합 츄어블정 및 그 제조방법 |
| MX2018011699A (es) * | 2018-09-26 | 2019-07-24 | Federico Amezcua Amezcua | Composicion farmaceutica sinergica de un antagonista de los receptores de leucotrienos y un agonista inverso de la histamina h1. |
| MA54707A (fr) * | 2019-01-10 | 2021-11-17 | Jiangyin Mucocare Pharmaceutical Co Ltd | Nouvelles formulations contenant des antagonistes des récepteurs des leucotriènes |
| EP4153178A4 (fr) | 2020-05-19 | 2024-06-05 | Irr, Inc. | Lévocétirizine et montélukast utilisés dans le traitement du sepsis et de ses symptômes |
| JP2024514989A (ja) * | 2021-10-21 | 2024-04-03 | ハン ファ ファーマ カンパニー、リミテッド | モンテルカストまたはその薬学的に許容可能な塩、及びレボセチリジンまたはその薬学的に許容可能な塩を含有する、安定性が改善されたフィルムコーティング錠剤 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI75816C (fi) | 1981-02-06 | 1988-08-08 | Ucb Sa | Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid. |
| GB8827391D0 (en) | 1988-11-23 | 1988-12-29 | Ucb Sa | Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride |
| DK0480717T3 (da) | 1990-10-12 | 1999-02-08 | Merck Frosst Canada Inc | Umættede hydroxyalkylquinolinsyrer som leukotrienantagonister |
| ES2122042T3 (es) | 1992-09-24 | 1998-12-16 | Sepracor Inc | Tratamiento de rinitis alergica y asma que emplea (-)cetirizina. |
| AU2003264859A1 (en) | 2001-12-21 | 2003-12-19 | Sampad Bhattacharya | Intranasal pharmaceutical compositions comprising an antihistamine and a leukotriene inhibitor |
| PT1976522E (pt) * | 2005-12-30 | 2013-09-09 | Krka Tovarna Zdravil D D Novo Mesto | Composição farmacêutica contendo montelucaste |
| CA2635841A1 (fr) | 2006-02-09 | 2007-08-16 | Teva Pharmaceutical Industries Ltd. | Formulations pharmaceutiques stables de montelukast sodique |
| US20090124657A1 (en) * | 2007-08-14 | 2009-05-14 | Ramesh Kappala | Pharmaceutical compositions comprising montelukast |
| WO2009122187A2 (fr) * | 2008-04-03 | 2009-10-08 | Cipla Limited | Composition pharmaceutique |
| WO2010107404A1 (fr) * | 2009-03-16 | 2010-09-23 | Mahmut Bilgic | Combinaisons pharmaceutiques stables |
-
2010
- 2010-11-11 TR TR2010/09398A patent/TR201009398A2/xx unknown
-
2011
- 2011-11-03 WO PCT/TR2011/000247 patent/WO2012064305A2/fr not_active Ceased
- 2011-11-03 WO PCT/TR2011/000243 patent/WO2012064301A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012064305A3 (fr) | 2012-08-09 |
| WO2012064301A2 (fr) | 2012-05-18 |
| WO2012064305A2 (fr) | 2012-05-18 |
| WO2012064301A3 (fr) | 2012-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201009398A2 (tr) | Fiziksel özellikleri geliştirilmiş tablet formülasyonları | |
| PH12014502577A1 (en) | Compositions comprising an anti-pdgf aptamer and a vegf antagonist | |
| MX366018B (es) | Composiciones de células t deficientes del receptor de células t. | |
| IL234508B (en) | Inhalation of nitric oxide for treating respiratory diseases | |
| IT1401979B1 (it) | Dispositivo biomedico per la riabilitazione robotizzata dell'arto superiore umano, particolarmente per la riabilitazione neuromotoria dell'articolazione della spalla e del gomito. | |
| WO2015031808A3 (fr) | Procédés de diagnostic et compositions pour le traitement d'un glioblastome | |
| JO3462B1 (ar) | أجسام مضادة بشرية تجاه gfr?3 وطرق لاستخدامها | |
| DK2800581T3 (da) | Fremgangsmåder til behandling af adfærdssymptomer på neurologiske og mentale forstyrrelser | |
| CR20110658A (es) | Antagonistas de la trayectoria hedgehog de ftalazina desustituida | |
| EA201500314A1 (ru) | Лекарственные формы энзалутамида | |
| LT4104824T (lt) | Kompozicijos, skirtos panaudoti taikant pacientams su didele širdies ir kraujagyslių ligos rizika antsvorio ir nutukimo gydymo būdą | |
| HK1207304A1 (en) | Crhr1 antagonists for use in the treatment of patients having crh overactivity | |
| CU24133B1 (es) | Polipéptidos que se enlazan a dr5 humana con efectos agonistas, que comprenden uno o más monómeros de un único dominio variable, utiles en el tratamiento de enfermedades y trastornos asociados con dr5 | |
| EA201390977A1 (ru) | Комбинация агониста опиоидных рецепторов и антагониста опиоидных рецепторов для лечения болезни паркинсона | |
| DK3065764T6 (da) | Mini-gastrin-analog, især til anvendelse i CCK-2-receptor-positive tumordiagnoser og/eller -behandling | |
| PT2501234T (pt) | Métodos e composições para o tratamento de sintomas associados com distúrbios de stress pós-traumático utilizando ciclobenzaprina | |
| EP2990017A4 (fr) | Dispositif portable pouvant traiter la maladie de meniere et des symptômes similaires a celle-ci | |
| IL312551A (en) | Grpr-antagonists for detection, diagnosis and treatment of grpr-positive cancer | |
| BR112012030331A2 (pt) | isoformas de neuregulin, polipeptídeos de neuregulin, e usos dos mesmos | |
| BR112015010039A2 (pt) | tratamento de câncer com pomalidomida em um individuo com disfunção renal | |
| TR201909158T4 (tr) | siRNA ve göz rahatsızlıklarının tedavisi ve/veya önlenmesine yönelik yöntemler ve bileşimlerde kullanımları. | |
| PL3678692T3 (pl) | Stratyfikacja genotypów w leczeniu i profilaktyce cukrzycy | |
| IT1398378B1 (it) | Citicolina per il trattamento del glaucoma e dell'ipertensione oculare. | |
| EA201491532A1 (ru) | Фармацевтические композиции для использования в комплексной терапии | |
| CO6592047A2 (es) | Formulación tópica oftálmica de péptidos |